Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Ketorolac for Acute Migraine
NCT00483717Phase 2Completed
- Sponsor
- Egalet
- Start
- Jul 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing Placebo with Ketorolac tromethamine (2 arms). Primary endpoint: The Number of Treated Subjects Who Became Pain-free (International Headache Society Grade of 0 = no Pain) by Observation Time Point at 2 hours. Started Jul 2007; status: completed.
02
Drugs
ketorolac
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00483717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483717.